1
|
Dong ZW and Yuan YF: Juglanin suppresses
fibrosis and inflammation response caused by LPS in acute lung
injury. Int J Mol Med. 41:3353–3365. 2018.PubMed/NCBI
|
2
|
Brun-Buisson C, Minelli C, Bertolini G,
Brazzi L, Pimentel J, Lewandowski K, Bion J, Romand JA, Villar J,
Thorsteinsson A, et al: Epidemiology and outcome of acute lung
injury in European intensive care units. Results from the ALIVE
study. Intensive Care Med. 30:51–61. 2004. View Article : Google Scholar : PubMed/NCBI
|
3
|
Gilliland FD, McConnell R, Peters J and
Gong H Jr: A theoretical basis for investigating ambient air
pollution and children's respiratory health. Environ Health
Perspect. 3:403–407. 1999. View Article : Google Scholar
|
4
|
Tang L, Zhang H, Wang C, Li H, Zhang Q and
Bai J: M2A and M2C macrophage subsets ameliorate inflammation and
fibroproliferation in acute lung injury through interleukin 10
pathway. Shock. 48:119–129. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
McArdle MA, Finucane OM, Connaughton RM,
McMorrow AM and Roche HM: Mechanisms of obesity-induced
inflammation and insulin resistance: Insights into the emerging
role of nutritional strategies. Front Endocrinol (Lausanne).
4:522013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Dai JP, Wang QW, Su Y, Gu LM, Zhao Y, Chen
XX, Chen C, Li WZ, Wang GF and Li KS: Emodin inhibition of
influenza A virus replication and influenza viral pneumonia via the
Nrf2, TLR4, p38/JNK and NF-kappaB pathways. Molecules.
22:E17542017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Wu J, Li L, Sun Y, Huang S, Tang J, Yu P
and Wang G: Altered molecular expression of the TLR4/NF-κB
signaling pathway in mammary tissue of Chinese Holstein cattle with
mastitis. PLoS One. 10:e01184582015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Yang J, Yang J, Ding JW, Chen LH, Wang YL,
Li S and Wu H: Sequential expression of TLR4 and its effects on the
myocardium of rats with myocardial ischemia-reperfusion injury.
Inflammation. 31:304–312. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Jiang S, Shan F, Zhang Y, Jiang L and
Cheng Z: Increased serum IL-17 and decreased serum IL-10 and IL-35
levels correlate with the progression of COPD. Int J Chron Obstruct
Pulmon Dis. 13:2483–2494. 2018. View Article : Google Scholar : PubMed/NCBI
|
10
|
Gately MK, Desai BB, Wolitzky AG, Quinn
PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizonnite
R, Gubler U, et al: Regulation of human lymphocyte proliferation by
a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation
factor). J Immunol. 147:874–882. 1991.PubMed/NCBI
|
11
|
Li X, Mai J, Virtue A, Yin Y, Gong R, Sha
X, Gutchigian S, Frisch A, Hodge I, Jiang X, et al: IL-35 is a
novel responsive anti-inflammatory cytokine-a new system of
categorizing anti-inflammatory cytokines. PLoS One. 7:e336282012.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang W, Li P and Yang J: Decreased
circulating interleukin-35 levels are related to
interleukin-4-producing CD8+ Tcells in patients with allergic
asthma. Iran J Allergy Asthma Immunol. 14:379–385. 2015.PubMed/NCBI
|
13
|
Li Y, Pan X, Peng X, Li S, Zhou Y, Zheng X
and Li M: Adenovirus-mediated interleukin-35 gene transfer
suppresses allergic airway inflammation in a murine model of
asthma. Inflamm Res. 64:767–774. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wu Q, Li R, Soromou LW, Chen N, Yuan X,
Sun G, Li B and Feng H: p-Synephrine suppresses
lipopolysaccharide-induced acute lung injury by inhibition of the
NF-κB signaling pathway. Inflamm Res. 63:429–439. 2014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Thomas NJ, Jouvet P and Willson D: Acute
lung injury in children-kids really aren't just ‘little adults’.
Pediatr Crit Care Med. 14:429–432. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Jiang Z, Chen Z, Li L, Zhou W and Zhu L:
Lack of SOCS3 increases LPS-induced murine acute lung injury
through modulation of Ly6C (+) macrophages? Respir Res. 18:2172017.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Egwuagu CE, Yu CR, Sun L and Wang R:
Interleukin 35: Critical regulator of immunity and
lymphocyte-mediated diseases. Cytokine Growth Factor Rev.
26:587–93. 2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Pan X, Xu K and Li Y, Wang X, Peng X, Li M
and Li Y: Interleukin-35 expression protects against cigarette
smoke-induced lung inflammation in mice. Biomed Pharmacother.
110:727–732. 2019. View Article : Google Scholar : PubMed/NCBI
|
19
|
Akira S and Takeda K: Toll-like receptor
signalling. Nat Rev Immunol. 4:499–511. 2004. View Article : Google Scholar : PubMed/NCBI
|
20
|
Qi W, Yang X, Ye N, Li S, Han Q, Huang J
and Wu B: TLR4 gene in the regulation of periodontitis and its
molecular mechanism. Exp Ther Med. 18:1961–1966. 2019.PubMed/NCBI
|
21
|
Zhu C, Bao NR, Chen S and Zhao JN: HBD-3
regulation of the immune response and the LPS/TLR4-mediated
signaling pathway. Exp Ther Med. 12:2150–2154. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Sun W, Gao Y, Yu X, Yuan Y, Yi J, Zhang Z,
Cheng Y, Li Y, Peng X and Cha X: ‘Psoriasis 1’ reduces
psoriasis-like skin inflammation by inhibiting the VDR-mediated
nuclear NF-κB and STAT signaling pathways. Mol Med Rep.
18:2733–2743. 2018.PubMed/NCBI
|
23
|
Wanner C, Inzucchi SE, Lachin JM, Fitchett
D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC
and Zinman B; EMPA-REG OUTCOME Investigators, : Empagliflozin and
progression of kidney disease in Type 2 diabetes. N Engl J Med.
375:323–334. 2016. View Article : Google Scholar : PubMed/NCBI
|